Clinical Manifestation and Outcomes of Neuroretinitis in Korea.
10.3341/jkos.2017.58.2.156
- Author:
Su Gyeong JANG
1
;
Kang Yeun PAK
;
Han Jo KWON
;
Seung Min LEE
;
Sung Who PARK
;
Ik Soo BYON
;
Ji Eun LEE
Author Information
1. Department of Ophthalmology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea. oph97@naver.com
- Publication Type:Original Article
- Keywords:
Neuroretinitis;
Ocular toxocariasis;
Optic neuritis;
Toxocara;
Toxocariasis
- MeSH:
Albendazole;
Enzyme-Linked Immunosorbent Assay;
Female;
Humans;
Korea*;
Male;
Optic Neuritis;
Retinitis*;
Retrospective Studies;
Toxocara;
Toxocariasis;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2017;58(2):156-164
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: In the present study, the clinical characteristics and outcomes of neuroretinitis in Korea were investigated. METHODS: Seven consecutive patients with neuroretinitis from 2012 to 2015 were retrospectively reviewed. RESULTS: The present study included 9 eyes of 7 patients. The subjects consisted of 5 males and 2 females and the mean age was 45.1 ± 13.2 years. Two patients had Influenza-like symptoms and the others had no specific general symptoms. The mean best corrected visual acuity was logMAR 0.48 ± 0.55 (0-1.6) on the initial visit. Four patients 40 years of age or under had no abnormal findings in laboratory work-up. Conversely, 3 patients over 40 years of age were positive for Toxocara based on enzyme-linked immunosorbent assay (ELISA). Two of 3 patients positive for Toxocara were treated with albendazole and 1was not. Eight eyes had good visual recovery over 20/30 except for 1 patient who did not take the albendazole despite being positive for Toxocara detected using ELISA. CONCLUSIONS: Three of 7 patients with neuroretinitis in Korea showed positive results for Toxocara based on ELISA. In cases with seropositive Toxocara ELISA results, albendazole treatment should be considered.
